Last Updated: 24/03/2025
TMA2019 IF [ BARRY]
Objectives
The set objectives for this industrial fellowship programme are:
- to acquire advanced statistical and data analysis skills applicable to clinical trials
- integration into an experienced multidisciplinary research team at the Institute for Tropical Medicine in Tübingen
- to attend specialised training workshops and international conferences
- to have hands-on training in a qualified laboratory
- skills transfer with peers/team working
- participation in lectures and courses from a recognized university
Nouhoun Barry, a medical doctor with experience in clinical research on poverty-related diseases in Burkina Faso, has been actively involved in various clinical trials implemented by his home institution, GRAS, in Burkina Faso, where he served as a study clinician. However, he noted that his research and clinical experience had been limited to his local institution. To gain more experience and develop advanced skills in conducting clinical trials beyond his home country, he was awarded a Clinical Research and Product Development Fellowship by the EDCTP2 Programme, which placed him at Eberhard Karls Universität Tübingen (EKUT) in Germany. In addition to gaining expertise in various laboratory methodologies and in drafting clinical protocols and manuscripts, the flexibility of the fellowship allowed Dr. Barry to pursue a doctoral program at EKUT. To fulfill the requirements for his doctoral degree, he attended several undergraduate courses at the university and optimized laboratory assays to analyze patient samples as part of his research.
During the reporting year, under the guidance of his doctoral supervisor, he attended courses such as Principles of Innate and Adaptive Immunity, Clinical Immunology, Advanced Immunology, Scientific Data Visualization, a statistics course on ANOVA, and Good Scientific Practice. Regarding laboratory assays, he conducted malaria antigen expression (production) and purification. Additionally, he utilized the expressed antigens to test reactivity against Plasmodium falciparum antigens through ELISA assays, using plasma samples from patients living in malaria-endemic countries. To date, four antigens have been tested and selected. Preliminary data were analyzed and presented at the 11th EDCTP Forum in Paris, France. The findings were subsequently updated and presented at the MIM2024 Conference (Multilateral Initiative on Malaria) in April 2024 in Kigali, Rwanda. Currently, Dr. Barry is in the process of writing his first manuscript and anticipates publishing it in the first quarter of 2025.
Jan 2023 — Dec 2025
$107,412
